Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile MILAN, Italy, October 07, 2025 – Italfarmaco S.p.A.

Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile Consistent efficacy demonstrated across age groups MILAN, ...

Health Canada approved AGAMREE for the treatment of Duchenne muscular dystrophy in patients aged 4 years and older This approval makes AGAMREE the first and only approved therapy for DMD in Canada ...

MISSISSAUGA, ON, Oct. 2, 2025 /PRNewswire/ - Kye Pharmaceuticals ("Kye") announced today that Health Canada has approved AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) in ...

Duchenne muscular dystrophy (DMD) causes muscle weakness that becomes more severe over time. While there is no cure, treatments can help slow the progression and manage symptoms and complications.

Good morning, and thank you so much for joining us today. I'm Kat Lange, Chief Business Officer at Avidity Biosciences. Today, we are excited to share the first functional data from the EXPLORE44 open ...

The Mercator world map, long a fixture in classrooms globally, makes the European Union appear almost as large as Africa. In reality, Africa is more than seven times bigger. It is a distortion that ...

Mice turning tiny steering wheels to move shapes on a screen have helped scientists produce the first brain-wide map of decision-making at single-cell resolution in a mammal. For decades, most ...

Toronto-based Satellos Bioscience is a clinical-stage small molecule development company focused on restoring natural muscle repair and regeneration for degenerative muscle diseases. Its lead drug ...

NEW YORK (PIX11) – Can’t figure out where to park in New York City? A map from the city’s Department of Transportation lays out where to find signs for metered parking, no standing, street cleaning ...